Evidence map›Paper›PMID 23027953›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein.

Megan H Orzalli, Neal A DeLuca, David M Knipe

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 311 papers.

0numbers the graph read from it
0cells of the map it votes in
311citing papers in PubMed
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

311 citing papers in PubMed, 416 citations in OpenAlex.

  1. IFN-κ directs antiviral immunity in human skin.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Expulsion of nuclear DNA to the cytoplasm after viral entry: A mechanism for activation of the cGAS pathway.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Next-generation replication-defective HSV vectors for delivery of large DNA payloads.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  18. Review
  19. Article
  20. The role of NJournal of virology · 2025
    Review

251 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Megan H OrzalliDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
Neal A DeLuca
David M Knipe
Harvard University · USUniversity of Pittsburgh · US

Funding

REPRESSION AND ACTIVATION OF PERSISTING HSV GENOMESR01AI044821 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 1999 to 2016
$4.3M
Innate Immunity and Herpes Simplex InfectionP01AI083215 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FINBERG, ROBERT WILLIAM · 2009 to 2010
$3.7M
Chromatin and Herpes Simplex Virus LatencyR01AI099081 · NIAID · HARVARD MEDICAL SCHOOL · PI KNIPE, DAVID M. · 2012 to 2013
$958k
NIAID NIH HHS AI099081NIAID NIH HHS AI83215NIAID NIH HHS P01 AI083215NIAID NIH HHS R01 AI044821NIAID NIH HHS R01 AI099081
6 · The paper itself

Abstract

Innate sensing of microbial components is well documented to occur at many cellular sites, including at the cell surface, in the cytosol, and in intracellular vesicles, but there is limited evidence of nuclear innate signaling. In this study we have defined the mechanisms of interferon regulatory factor-3 (IRF-3) signaling in primary human foreskin fibroblasts (HFF) infected with herpes simplex virus 1 (HSV-1) in the absence of viral gene expression. We found that the interferon inducible protein 16 (IFI16) DNA sensor, which is required for induction of IRF-3 signaling in these cells, is nuclear, and its localization does not change detectably upon HSV-1 d109 infection and induction of IRF-3 signaling. Consistent with the IFI16 sensor being nuclear, conditions that block viral DNA release from incoming capsids inhibit IRF-3 signaling. An unknown factor must be exported from the nucleus to activate IRF-3 through cytoplasmic STING, which is required for IRF-3 activation and signaling. However, when the viral ICP0 protein is expressed in the nucleus, it causes the nuclear relocalization and degradation of IFI16, inhibiting IRF-3 signaling. Therefore, HSV-1 infection is sensed in HFF by nuclear IFI16 upon release of encapsidated viral DNA into the nucleus, and the viral nuclear ICP0 protein can inhibit the process by targeting IFI16 for degradation. Together these results define a pathway for nuclear innate sensing of HSV DNA by IFI16 in infected HFF and document a mechanism by which a virus can block this nuclear innate response.

Indexed as

Cells, CulturedDNA, ViralFlow CytometryFluorescent Antibody Technique, IndirectHerpes LabialisHerpesvirus 1, HumanHumansImmediate-Early ProteinsInterferon Regulatory Factor-3Nuclear ProteinsPhosphoproteinsPolymerase Chain ReactionSignal TransductionUbiquitin-Protein LigasesDNA, ViralIFI16 protein, humanImmediate-Early ProteinsInterferon Regulatory Factor-3Nuclear ProteinsPhosphoproteinsUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1

Identifiers

PMID23027953
PMCPMC3497734
OpenAlexW2163362670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.